维普期刊资源整合服务平台（V6.5）

25篇 您的检索式：作者名="Wirth LJ"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Motesanib diphosphate in progressive differentiated thyroid cancer 显示文摘	Sherman SI Wirth LJ Droz JP	2008	N Engl J Med2008，359，1：	1
2	Seeking alter-native biological therapies:The future of targeted mo-lecular treatment显示文摘	Lorch JH Posner MR Wirth LJ	2009	Oral Oncology2009，45，：	1
3	Lenva- tinib versus placebo in radioiodine-refractory thyroid cancer显示文摘	SCHLUMBERGER M TAHARA M WIRTH LJ	2015	N Engl J Med2015，372，7：	1
4	Motesanib diphosphate in progressive differentiated thyroid cancer显示文摘	Sherman SI Wirth LJ Droz JP		0，，：	1
5	Motesanib diphosphate in progressive differentiated thyroid cancer显示文摘	Sherman SI Wirth LJ Droz JP	2008	N Engl J Med2008，359，1：	1
6	Outcome of patients with pulmonary carcinoid tumors receiving chemotherapy or chemoradiotherapy显示文摘	Wirth LJ Carter MR Janne PA	2004	Lung Cancer2004，44，2：	1
7	Seeking alternative biologi?cal therapies: the future of targeted molecular treatment显示文摘	LorchJ H Posner MR Wirth LJ	2009	Oral Oncol2009，45，4：	1
8	Cetuximab added to docetaxel,cisplatin,5-fluorouracil induction chemotherapy in patients with newly diagnosed locally advanced head and neck cancer:a phase I study显示文摘	Tishler RB Posner MR Wirth LJ	2008	J Clin Oncol2008，，：	1
9	Motesanib diphosphate in progressive differentiated thyroid cancer 显示文摘	Sherman SI Wirth LJ Droz JP	2008	N Engl J Med2008，359，1：	1
10	Lenvatinib versus placebo in radioiodine-refractory thyroid cancer 显示文摘	Schlumberger M Tahara M Wirth LJ	2015	N Engl J Med2015，372，7：	1
11	Lenvatinib versus placebo in radioiodine-refractory thyroid cancer 显示文摘	Schlumherger M1 Tahara M Wirth LJ	2015	N Engl J Med2015，372，7：	1
12	Motesanib diphosphate in progressive differentiated thyroid cancer显示文摘	SHERMAN SI WIRTH LJ DROZ JP	2008	N Engl J Med2008，359，1：	1
13	Lenvatinib versus placebo in radioiodine-refractory thyroid cancer 显示文摘	Schlumberger M Tahara M Wirth LJ	2015	N Eng J Med2015，372，7：	1
14	Phase I study of gefitinib plus celecoxib in recurrent or metastatic squamous cell carcinoma of the head and neck显示文摘	Wirth LJ Haddad RI Lindeman NI	2005	J Clin Oncol2005，23，34：	1
15	Outcome of patients with pulmonary carcinoid tumors receving chemotherapy or chemoradiotherapy 显示文摘	Wirth LJ Carter MR Janne PA	2004	Lung Cancer2004，44，：	1
16	Motesanib diphosphate in progressive differentiated thyroid cancer显示文摘	Sherman SI Wirth LJ Droz JP	2008	N Engl J Med2008，359，：	1
17	Motesanib Diphosphate in Progressive Differentiated Thyroid Cancer显示文摘	Sherman Sl Wirth LJ Droz JP	2008	N Engl J Med2008，359，：	1
18	Lenvatinib versus placebo in radioiodine-refractory thyroid cancer显示文摘	Schlumberger M Tahara M Wirth LJ	2015	N Engl J Med2015，372，7：	1
19	Cetuximab and radiotherapy for head and neck cancer显示文摘	Posner MR wirth LJ	2006	N Engl J Med2006，354，6：	1
20	Motesanib diphosphate in progressive differentiated thyroid cancer显示文摘	Sherman SI Wirth LJ Droz JP	2008	N Engl J Med2008，359，1：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示